Literature DB >> 857843

Monocyte recruitment in tuberculosis and sarcoidosis.

E Schmitt, G Meuret, L Stix.   

Abstract

Monocytopoiesis and blood monocytes were investigated in nine patients with active tuberculosis and in six patients with active sarcoidosis in order to obtain information on monocyte consumption in these two types of granuloma. All patients with tuberculosis demonstrated a marked increase in proliferation activity of monocytopoiesis and premature monocyte marrow release. These changes indicate a high monocyte consumption which probably is caused by a high macrophage death rate due to the high macrophage-toxicity of tubercle bacilli. Thus, tuberculous lesions are an example of a "high turnover granuloma". In sarcoidosis monocytopoiesis showed no significant deviations from the normal. This indicates a low macrophage turnover or "low turnover granuloma". Thus, any hypothetical agent assumed to be involved in the pathogenesis of sarcoidosis would have to possess low macrophage-toxicity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 857843     DOI: 10.1111/j.1365-2141.1977.tb00557.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

1.  Role of cytomorphology in differentiating sarcoidosis and tuberculosis in subjects undergoing endobronchial ultrasound-guided transbronchial needle aspiration.

Authors:  Valliappan Muthu; Nalini Gupta; Sahajal Dhooria; Inderpaul Singh Sehgal; Kuruswamy Thurai Prasad; Ashutosh Nath Aggarwal; Ritesh Agarwal
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

Review 2.  Immunopathology of tuberculosis: roles of macrophages and monocytes.

Authors:  M J Fenton; M W Vermeulen
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

3.  Disorders of the mononuclear phagocyte system. An analytical review.

Authors:  G Meuret
Journal:  Blut       Date:  1977-04

4.  An evolutionary recent IFN/IL-6/CEBP axis is linked to monocyte expansion and tuberculosis severity in humans.

Authors:  Murilo Delgobo; Daniel Agb Mendes; Edgar Kozlova; Edroaldo Lummertz Rocha; Gabriela F Rodrigues-Luiz; Lucas Mascarin; Greicy Dias; Daniel O Patrício; Tim Dierckx; Maíra A Bicca; Gaëlle Bretton; Yonne Karoline Tenório de Menezes; Márick R Starick; Darcita Rovaris; Joanita Del Moral; Daniel S Mansur; Johan Van Weyenbergh; André Báfica
Journal:  Elife       Date:  2019-10-22       Impact factor: 8.140

Review 5.  Macrophage activation, chronic inflammation and gastrointestinal disease.

Authors:  A R Tanner; M J Arthur; R Wright
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

6.  Immunofluorescent localization of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas.

Authors:  E Silverstein; L P Pertschuk; J Friedland
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

7.  Low local blood perfusion, high white blood cell and high platelet count are associated with primary tumor growth and lung metastasis in a 4T1 mouse breast cancer metastasis model.

Authors:  Chuan Wang; Ying-Ge Chen; Jian-Li Gao; Gui-Yuan Lyu; Jie Su; Q I Zhang; Xin Ji; Ji-Zhong Yan; Qiao-Li Qiu; Yue-Li Zhang; Lin-Zi Li; Han-Ting Xu; Su-Hong Chen
Journal:  Oncol Lett       Date:  2015-06-02       Impact factor: 2.967

8.  Inhibition of response to alpha interferon by Mycobacterium tuberculosis.

Authors:  Savita Prabhakar; Yaming Qiao; Yoshihiko Hoshino; Michael Weiden; Antony Canova; Elena Giacomini; Eliana Coccia; Richard Pine
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

9.  Monocytopoiesis in malignant melanoma: untreated, during immunotherapy and chemoimmunotherapy.

Authors:  E Schmitt; G Meuret; F Waldermann; M Hagedorn
Journal:  Arch Dermatol Res       Date:  1979-05-04       Impact factor: 3.017

10.  Host gene-encoded severe lung TB: from genes to the potential pathways.

Authors:  M Ganachari; H Guio; N Zhao; P O Flores-Villanueva
Journal:  Genes Immun       Date:  2012-09-20       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.